CRSP
CRSP
NASDAQ · Biotechnology

Crispr Therapeutics Ag

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$46.43
-0.45 (-0.96%)
As of Mar 24, 9:54 PM ET ·
Analyst Consensus
Buy
35
Analysts
Very High
Coverage
Buy 22 63%
Hold 12 34%
Sell 1 3%
Price Target
Analyst Price Target +139.2% upside
Low Target $83.97
Average Target $111.08
High Target $162.31
Current Price $46.43
Current
$46.43
Target
$111.08
$83.97 $111.08 avg $162.31
Scenario Analysis
Bear Case
$83.97
80.9%
Low target
Base Case
$111.08
+139.2%
Avg target
Bull Case
$162.31
+249.6%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$78.48
-40.8% from high
52-Week Low
$30.04
+54.6% from low
50-Day SMA
$54.19
-14.3% vs SMA
200-Day SMA
$54.12
-14.2% vs SMA
RSI (14)
52.8
Neutral
Target vs 52W High
$111.08
+41.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%